EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

GLP-1 Receptor Agonists and Insulin Versus Insulin for Perioperative Glycemic Control in Patients with Type 2 Diabetes Undergoing Cardiac Surgery: A Systematic Review

Danish Hassan, Rida Shakeel, Waleed Qaisi, Syed Rayyan Ahmed, Javeria Taj, Mohammad Adi, Ahmed Yousry Ahmed, Ammir Abuzahra, Emad Uddin Sajid, Hamza Arshad Khan, Tuba Basit, Javed Iqbal und 1 weitere

Annals of Cardiac Anaesthesia · 2026

DOI: 10.4103/aca.aca_307_25 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Cardiac Anaesthesia, 2026. Verfasst von Danish Hassan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dow University of Health Sciences, Dow Medical College, Karachi, Pakistan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Insulin, Hypoglycemic Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perioperative hyperglycemia is common in patients with type 2 diabetes undergoing cardiac surgery and is linked to adverse outcomes. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer glucose-dependent insulinotropic effects and potential cardiac benefits, but their perioperative role remains uncertain. This review evaluated the efficacy and safety of GLP-1 RA therapy as an adjunct to insulin in this setting. Three electronic databases (PubMed, Cochrane, and Google Scholar) were searched for relevant articles up to October 2025. The primary endpoint was blood glucose levels during the perioperative period, while secondary endpoints included hypoglycemia incidence, total insulin requirement, time in target glucose range, and postoperative complications. Three randomized controlled trials (RCTs) including 168 patients with type 2 diabetes undergoing cardiac surgery were assessed. Perioperative use of liraglutide (subcutaneously in doses of 0.6-1.8 mg/day) was associated with preliminary evidence of improved glycemic control across preoperative, intraoperative, and early postoperative periods, including lower glucose levels, reduced glycemic variability, and fewer insulin adjustments, with a low incidence of hypoglycemia. However, heterogeneity in dosing, timing, and monitoring protocols across studies limits direct comparisons. Mild gastrointestinal adverse events, such as nausea and vomiting, were more frequent with liraglutide. One study reported exploratory immunometabolic effects in adipose tissue. Preliminary evidence from these heterogeneous studies suggests that adding liraglutide to insulin may improve perioperative glycemic control compared to insulin or placebo in patients with type 2 diabetes undergoing cardiac surgery. However, findings are limited by the small number of studies, methodological variability, and lack of long-term outcomes, necessitating larger, standardized trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsInsulinHypoglycemic AgentsGlycemic ControlCardiac Surgical ProceduresPerioperative CareHumansBlood GlucoseLiraglutideHyperglycemia

Stichwörter der Autor:innen

Cardiac surgeryGLP-1 receptor agonistglycemic controlinsulinliraglutideperioperative managementtype 2 diabetes

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsInsulinHypoglycemic AgentsBlood GlucoseLiraglutide

Autor:innen und Institutionen

  • Department of Medicine, Dow University of Health Sciences, Dow Medical College, Karachi, Pakistan.
  • Department of Medicine, An-Najah National University, Nablus, Palestine.
  • Faculty of Medicine, Damascus University, Damascus, Syria.
  • KFS University, Faculty of Medicine and Rehabilitation / Intern Student, Egypt.
  • Faculty of Medicine, Hebron University, Hebron, Palestine.
  • Department of Medicine, Al-Tibri Medical College, Isra University, Karachi, Pakistan.

Zitieren

APA

Hassan, D., Shakeel, R., Qaisi, W., Ahmed, S. R., Taj, J., Adi, M., Ahmed, A. Y., Abuzahra, A., Sajid, E. U., Khan, H. A., Basit, T., Iqbal, J., & Hussain, A. (2026). GLP-1 Receptor Agonists and Insulin Versus Insulin for Perioperative Glycemic Control in Patients with Type 2 Diabetes Undergoing Cardiac Surgery: A Systematic Review. Annals of Cardiac Anaesthesia. https://doi.org/10.4103/aca.aca_307_25

Vancouver

Hassan D, Shakeel R, Qaisi W, Ahmed SR, Taj J, Adi M, et al. GLP-1 Receptor Agonists and Insulin Versus Insulin for Perioperative Glycemic Control in Patients with Type 2 Diabetes Undergoing Cardiac Surgery: A Systematic Review. Annals of Cardiac Anaesthesia. 2026. doi:10.4103/aca.aca_307_25

BibTeX
@article{Hassan2026,
  author = {Hassan, Danish and Shakeel, Rida and Qaisi, Waleed and Ahmed, Syed Rayyan and Taj, Javeria and Adi, Mohammad and Ahmed, Ahmed Yousry and Abuzahra, Ammir and Sajid, Emad Uddin and Khan, Hamza Arshad and Basit, Tuba and Iqbal, Javed and Hussain, Asraf},
  title = {GLP-1 Receptor Agonists and Insulin Versus Insulin for Perioperative Glycemic Control in Patients with Type 2 Diabetes Undergoing Cardiac Surgery: A Systematic Review},
  journal = {Annals of Cardiac Anaesthesia},
  year = {2026},
  doi = {10.4103/aca.aca_307_25}
}
Kostenlos starten →